KATHERINE A NAFF to Receptor, ErbB-2
This is a "connection" page, showing publications KATHERINE A NAFF has written about Receptor, ErbB-2.
Connection Strength
0.026
-
Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. PLoS One. 2015; 10(9):e0136851.
Score: 0.016
-
Development of a targeted gene vector platform based on simian adenovirus serotype 24. J Virol. 2010 Oct; 84(19):10087-101.
Score: 0.011